GlassScriptPhysician profile
Tsz Y Lau
NPI 1326237389
$164,497.21
in general payments reported to CMS, 2019-2025
34 companies · $135K in 2025
The $135K reported for 2025 was more than what 98% of Neurological Surgery providers received nationally (typical 2025 total: $604).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $5,652 · 2020: $217 · 2021: $1,874 · 2022: $1,912 · 2023: $11K · 2024: $9,091 · 2025: $135K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $104K · Travel and Lodging: $24K · Consulting Fee: $19K · Food and Beverage: $8,040.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $103,687.50 |
| Travel and Lodging | $24,085.77 |
| Consulting Fee | $19,030.00 |
| Food and Beverage | $8,039.81 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $128,212.85 | 2022-2025 | Enroute Transcarotid Neuroprotection System, Enroute Transcarotid Stent, General - Therapies |
| Stryker Corporation | $20,127.28 | 2019-2025 | Trevo, Surpass Evolve, Target |
| Ulrich Medical USA, INC. | $5,573.09 | 2019-2023 | |
| Rapid Medical LTD | $2,302.82 | 2024-2025 | Comaneci 17, Tigertriever 17 Revascularization Device |
| Medtronic, INC. | $2,191.39 | 2021-2025 | Stealthstation S8 Platform, Strata, Axium Primetm |
| Silk Road Medical, INC. | $1,461.32 | 2019-2024 | Enroute Transcarotid Neuroprotection System, Enroute Transcarotid Stent, Enroute Enflate Transcarotid Rx Balloon Dilatation Catheter |
| Leica Microsystems (Schweiz) Ag | $880.00 | 2024 | Surgical Microscopes |
| Baxter Healthcare | $584.48 | 2023-2025 | Perclot, Floseal |
| Globus Medical, INC. | $553.67 | 2022-2025 | Excelsius Gps, Maxcess, Hedron |
| Depuy Synthes Sales INC. | $429.60 | 2019-2023 | Symphony |
| Zimmer Biomet Holdings, INC. | $270.43 | 2019-2021 | |
| Imperative Care, INC | $220.39 | 2023 | Zoom 88-T Large Distal Platform |
| Integra Lifesciences Corporation | $213.78 | 2021-2022 | |
| Cardiva Medical, INC. | $205.07 | 2019-2023 | Cardiva Vascade 6/7f Vcs, Cardiva Vascade Mvp Vvcs 6-12f |
| Microtransponder, INC. | $178.29 | 2024 |
Show all 34 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zimvie INC. | $150.00 | 2022 | |
| Life Spine, INC. | $120.64 | 2022 | |
| Medtronic USA, INC. | $105.20 | 2019-2020 | |
| Route 92 Medical, INC. | $92.91 | 2024 | 8f Base Camp Sheath System |
| Lundbeck LLC | $80.44 | 2024 | Vyepti |
| Microvention, INC. | $70.49 | 2020 | |
| Nsk America Corporation | $62.75 | 2025 | |
| Karl Storz Endoscopy-America | $61.46 | 2023 | |
| Penumbra, INC. | $52.15 | 2019 | |
| Amneal Pharmaceuticals LLC | $47.66 | 2021 | |
| Ucb, INC. | $46.30 | 2024-2025 | Rystiggo |
| Neurocrine Biosciences, INC. | $41.94 | 2024-2025 | Ingrezza |
| Janssen Biotech, INC. | $30.23 | 2025 | |
| Janssen Pharmaceuticals, INC | $25.00 | 2021 | |
| Merz Pharmaceuticals, LLC | $24.28 | 2024 | Xeomin |
| Takeda Pharmaceuticals U.S.A., INC. | $23.99 | 2024 | Hyqvia |
| Grifols USA, LLC | $19.80 | 2025 | Gamunex-C |
| Ethicon US, LLC | $19.10 | 2020 | |
| Novartis Pharmaceuticals Corporation | $18.41 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Tsz Lau listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.